COVID-19 Vaccines in Pregnancy May Protect Baby, Too

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Women who receive COVID-19 vaccines during pregnancy pass antibodies to their babies, which could protect newborns from the disease, research has shown.

In a new study that examines umbilical cord blood from 36 deliveries, researchers provide additional evidence that vaccines – and not COVID-19 infections – elicited the antibodies detected in this cohort.

Researchers with New York University Langone Health conducted a study that included pregnant women who had received at least one dose of an mRNA COVID-19 vaccine (Pfizer/BioNTech or Moderna) by June 4.

All neonates had antibodies to the spike protein at high titers, the researchers found.

Unlike similar prior studies, the researchers also looked for antibodies to the nucleocapsid protein, which would have indicated the presence of antibodies from natural COVID-19 infection. They did not detect antibodies to the nucleocapsid protein, and the lack of these antibodies suggests that the antibodies to the spike protein resulted from vaccination and not from prior infection, the researchers said.

The participants had a median time from completion of the vaccine series to delivery of 13 weeks. The study was published online in the American Journal of Obstetrics & Gynecology MFM.

“The presence of these anti-spike antibodies in the cord blood should, at least in theory, offer these newborns some degree of protection,” said study investigator Ashley S. Roman, MD, director of the division of maternal-fetal medicine at NYU Langone Health. “While the primary rationale for vaccination during pregnancy is to keep moms healthy and keep moms out of the hospital, the outstanding question to us was whether there is any fetal or neonatal benefit conferred by receiving the vaccine during pregnancy.”

Questions remain about the degree and durability of protection for newborns from these antibodies. An ongoing study, MOMI-VAX, aims to systematically measure antibody levels in mothers who receive COVID-19 vaccines during pregnancy and in their babies over time.

The present study contributes welcome preliminary evidence suggesting a benefit to infants, said Emily Adhikari, MD, of the University of Texas Southwestern Medical Center in Dallas, who was not involved in the study.

Still, “the main concern and our priority as obstetricians is to vaccinate pregnant women to protect them from severe or critical illness,” she said.

Although most individuals infected with SARS-CoV-2 recover, a significant portion of pregnant women get seriously sick, Adhikari said. “With this recent Delta surge, we are seeing more pregnant patients who are sicker,” said Adhikari, who has published research from one hospital describing this trend.

When weighing whether patients should receive COVID-19 vaccines in pregnancy, the risks from infection have outweighed any risk from vaccination to such an extent that there is “not a comparison to make,” Adhikari said. “The risks of the infection are so much higher.

“For me, it is a matter of making sure that my patient understands that we have really good safety data on these vaccines and there is no reason to think that a pregnant person would be harmed by them. On the contrary, the benefit is to protect and maybe even save your life,” Adhikari said. “And now we have more evidence that the fetus may also benefit.”

The rationale for vaccinations during pregnancy can vary, Roman said. Flu shots in pregnancy mainly are intended to protect the mother, though they confer protection for newborns as well. With the whooping cough vaccine given in the third trimester, however, the primary aim is to protect the baby from whooping cough in the first months of life, Roman said.

“I think it is really important for pregnant women to understand that antibodies crossing the placenta is a good thing,” she added.

As patients who already have received COVID-19 vaccines become pregnant and may become eligible for a booster dose, Adhikari will offer it, she said, though she has confidence in the protection provided by the initial immune response.

Roman and Adhikari had no disclosures.

This article originally appeared on MDedge.com, part of the Medscape Professional Network.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Labor positions thumbnail

Labor positions

There's no one position that's best when you're in labor. Trying different positions throughout labor can help you cope with the pain and feel more in control. Some research suggests that certain positions may be useful in moving labor along. And as labor goes on, switching positions can make you feel more comfortable. With some
Read More
‘김건희 무속 중독’ 기사 내려 달라고 요구한 국민의힘 thumbnail

‘김건희 무속 중독’ 기사 내려 달라고 요구한 국민의힘

“정론지에서 익명의 무속인 제보 내용을 객관적으로 전혀 검증하지 않고 그대로 옮기다니 너무 안타깝다” 윤석열 국민의힘 대선 후보의 부인 김건희 코바나컨텐츠 대표. 국회사진기자단 국민의힘은 22일 윤석열 대선 후보의 부인 김건희씨가 ‘무속 중독’이라고 보도한 매체에 “사실무근이니 기사를 내려달라”라고 요구했다고 전했다. 이양수 선대본주 수석대변인은 이날 논평에서 “오늘 경향신문 ‘김건희 무속 중독 논란, 핵심은 비선권력’ (제목의) 기사는 익명의 제보자들 얘기를…
Read More
USPSTF Says Evidence Still Lacking for AF Screening thumbnail

USPSTF Says Evidence Still Lacking for AF Screening

A new statement from the US Preventive Services Task Force (USPSTF) concludes that current evidence is insufficient to assess the balance of benefits and harms of screening for atrial fibrillation (AF) in asymptomatic adults. The guidance is similar to the Task Force's 2018 statement on screening for AF with electrocardiography (ECG) in asymptomatic adults 65…
Read More
Omicron is gaining ground: Protect, prevent, prepare thumbnail

Omicron is gaining ground: Protect, prevent, prepare

Statement by Dr Hans Henri P. Kluge, WHO Regional Director for Europe21 December 2021Last week, Europe and central Asia saw 27 000 additional COVID-19 deaths and 2.6 million new cases. Infections, still predominantly from the Delta variant, are 40% higher now than during the same period last year.Since its identification, 27 days ago, the Omicron…
Read More
Researchers provide a framework to study precision nutrigeroscience thumbnail

Researchers provide a framework to study precision nutrigeroscience

A framework for precision nutrigeroscience based on optimizing diet/pharmacology based interventions to optimize health and longevity to accommodate factors that lead to individual variation. We propose the concept of precision nutrigeroscience, the study of which will aim to utilize nutrient interventions and compounds that influence nutrient signaling pathways to optimize lifespan, healthspan and tissue-specific decline.…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share